eli lilly to acquire morphic in $3.2b deal
Published 1 month ago • 1.6K plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:54
eli lilly to acquire morphic therapeutics for $3.2 billion in cash
-
7:33
why eli lilly is a top glp-1 stock: roundhill ceo
-
2:01
eli lilly: becoming the world's biggest pharmaceutical company 1876-2024
-
0:31
lilly to acquire biopharmaceutical company morphic
-
1:21
eli lilly sells cheaper zepbound option to meet demand | reuters
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
1:08:20
new challenge! mounjaro/zepbound week #34 live q & a hrt week #7
-
4:24
eli lilly price target raised by $300 to $1,025 by deutsche bank
-
0:27
eli lilly now selling zepbound vials at 50% discount
-
3:06
eli lilly to release single-dose vials of zepbound to improve access
-
3:39
what eli lilly, novo nordisk earnings show about glp-1 sales
-
1:26
eli lilly stock upgraded to buy on forecast for new diabetes drug
-
0:55
eli lilly beats on q3 earnings, cites diabetes drug demand
-
6:55
stocks: reasons to go in on eli lilly stock, but avoid tesla
-
8:30
strategist: buy baxter stock, skip eli lilly stock
-
6:33
eli lilly stock gains on weight loss drug that cuts type 2 diabetes risk by 94%
-
4:09
excitement grows around eli lilly's glp-1 drugs in q2 earnings
-
3:35
eli lilly stock soars on earnings, 'off-the-charts' demand for weight-loss drugs
-
11:14
is eli lilly stock a buy now!? lly stock analysis
-
4:38
eli lilly closer to securing fda approval for alzheimer's drug
-
47:05
eli lilly to purchase morphic, green hydrogen | bloomberg intelligence